← All trials
NCT00554515
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2006
- Primary completion
- Oct 31, 2013
- Completion date
- Oct 31, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 123
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Harvard UniversityLead sponsor
- Indiana UniversityCollaborator
- Loyola UniversityCollaborator
- Our Lady of Mercy Medical CenterCollaborator
- University of California, Los AngelesCollaborator
- University of CincinnatiCollaborator
- University of PittsburghCollaborator
- University of VirginiaCollaborator
- Vanderbilt UniversityCollaborator
- Wayne State UniversityCollaborator
- Indiana UniversityOverall official - principal investigator
- Loyola UniversityOverall official - principal investigator
- University of California, Los AngelesOverall official - principal investigator
- University of CincinnatiOverall official - principal investigator
- University of PittsburghOverall official - principal investigator
- University of VirginiaOverall official - principal investigator
- Vanderbilt UniversityOverall official - principal investigator
- Wayne State UniversityOverall official - principal investigator
- City of Hope National Medical CenterOverall official - principal investigator
- Chiles Cancer CenterOverall official - principal investigator
- Our Lady of Mercy Cancer CenterOverall official - principal investigator
- Dartmouth UniversityOverall official - principal investigator
- City of Hope National Medical CenterCollaborator
- Dartmouth UniversityCollaborator
- Harvard UniversityStudy chair
- Harvard UniversityReponsible party - principal investigator
- State University of New York, BuffaloOverall official - principal investigator
- State University of New York, BuffaloCollaborator
- Providence Health & ServicesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.